Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO


Alamar, a maker of medical devices focused on studying proteins and disease detection, set up Attovia as a separate company in 2023, and remains an investor. Alamar raised $219.9 million in an IPO, and the shares have climbed 43% since its debut in April.



Source link

  • Related Posts

    Blue Owl’s Stack Seeks $5.9 Billion Loan, Extending AI Debt Boom

    Australia is emerging as one of the most attractive markets in Asia Pacific for data centers, in part due to its massive land area, as well as abundant renewable energy…

    Digital banks, social media, and the competition for deposits

    Over the past decade, two major digital trends have affected large parts of the population: the digitalisation of banking services, including the ability to manage deposit accounts remotely; and the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Blue Owl’s Stack Seeks $5.9 Billion Loan, Extending AI Debt Boom

    Digital banks, social media, and the competition for deposits

    Feds find funding for residential school survivors, providers to travel for counselling

    Feds find funding for residential school survivors, providers to travel for counselling

    The moment a Japanese mall explodes after a 6.8 earthquake

    The moment a Japanese mall explodes after a 6.8 earthquake

    Multiple football coaches, players charged over alleged hazing at Pennsylvania high school

    Multiple football coaches, players charged over alleged hazing at Pennsylvania high school

    Anthony Fauci pleads the Fifth amid attacks at US Senate COVID hearing